Innovative Journal Journal of Medical Biomedical and Applied Sciences 2589-8779 03 05 Potential Use of Cellular Stromal Vascular Fraction in Post-COVID-19 Pulmonary Injury and Adult Respiratory Distress Syndrome 1 Robert W Alexander United States of America; University of Washington (Seattle), Department of Surgery, School of Medicine & Dentistry Global Alliance of Regenerative Medicine Journal Article https://doi.org/10.15520/jcmro.v3i05.289 Abstract: A coronavirus (nCoV-2) has caused a worldwide pandemic, beginning in Wuhan, China. Patient’s acquiring viral infection (COVID-19) which is often featured by elevation of temperature (>100.3 F°), cough, severe fatigue, and a variety of symptoms mimicking the flu and pneumonias. This gradually may extend to a progressive and serious respiratory failure with associated ARDS-like status and severe pneumonias with residual scarring of the interstitial areas of the lung alveoli, resulting in acute life-threatening, and permanent compromised gas exchange. Those that survive with controlled ventilation (low tidal volumes), medical induced coma, and prone positioning, are often left with reduction in pulmonary function abilities. This paper reviews some pertinent knowledge and advances in understanding of the pulmonary injuries and long-term damage of the COVID-19 patients, and reports a study to ameliorate such damage with use of cSVF for those who successfully recover. There now exists technology to perform sophisticated analytics (Functional Respiratory Imaging, FRI) developed by Fluidda (Belgium, EU) which provides great detail and information, including the ability to help triage the infected patients early to help assist in prediction of ventilation and ICU needs. In addition, author’s experience with use in Chronic Obstructive Pulmonary Disease (COPD) and Fibrotic Lung Diseases, the ability to evaluate effectiveness of use of cellular Stromal Vascular Fraction (cSVF) following intravascular deployment of isolated and concentrated cSVF. The hypothesis is that reduction of the widespread pulmonary inflammatory and immune responses which destroy much of the gas exchange abilities in the acute and residual damage which appears to create a long-term problem in the surviving patient population. Fluidda imaging analytics, coupled with standard pulmonary function studies, are effective at predictive studies which may prove of great help in anticipating which patient group is at most risk in the earlier infections to require ICU and potential ventilation needs. Use of Stromal Vascular Fraction Cells (cSVF) are known to help mitigate damage from severe inflammatory disorders, provide immunomodulation, and promote repair and regenerative effects. The ease of access, simple ability to obtain significant numbers of viable cell elements, and the deployment via intravascular route has proven safe and efficacious in other forms of lung disease, including fibrotic lung disorders. This paper reviews many of the current issues facing the severely infected Post-COVID-19 patient’s lung compromise, and a therapeutic option which clearly shows promise to reverse some residual damage of the lung and gas exchange functions. Alexander, Robert W, Understanding Adipose-Derived Stromal Vascular Fraction (AD-SVF) Cell Biology and Use on the Basis of , Chemical, Structural and Paracrine Components, J. of Prolotherapy, 2012, 4, 855, 869 Alexander, Robert W, Overview of Cellular Stromal Vascular Fraction (cSVF) & Biocellular Use, J Stem Cell Res Dev, 1003 Atluri, S, Expanded Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Strategy In Managing Critically Ill COVID-19 Patients, Pain Physician, 2020, 23, 71, 83 Clukers, J., Lanclus, M., Mignot, B., Van Holsbeke, C., Roseman, J., Porter, S., Gorina, E., Kouchakji, E., Lipson, K. E., De Backer, W., De Backer, J., Quantitative CT analysis using functional imaging is superior in describing disease progression in idiopathic pulmonary fibrosis compared to forced vital capacity, Respiratory Research, 2018, 19, 1, 213, 222, 1465-993X, 10.1186/s12931-018-0918-5, Springer Science and Business Media LLC, https://dx.doi.org/10.1186/s12931-018-0918-5 Alexander, Robert, Harrell, David, Autologous fat grafting: use of closed syringe microcannula system for enhanced autologous structural grafting, Clinical, Cosmetic and Investigational Dermatology, 2013, 6, 91, 91, 1178-7015, 10.2147/ccid.s40575, Informa UK Limited, https://dx.doi.org/10.2147/ccid.s40575 Lanclus, Maarten, Clukers, Johan, Van Holsbeke, Cedric, Vos, Wim, Leemans, Glenn, Holbrechts, Birgit, Barboza, Katherine, De Backer, Wilfried, De Backer, Jan, Machine Learning Algorithms Utilizing Functional Respiratory Imaging May Predict COPD Exacerbations, Academic Radiology, 2019, 26, 9, 1191, 1199, 1076-6332, 10.1016/j.acra.2018.10.022, Elsevier BV, https://dx.doi.org/10.1016/j.acra.2018.10.022 De Backer, J W, De Backer, W, Flow Analyses in the Lower Airways: Patient-Specific Model and Boundary Conditions, Med Eng & Physics, 2008, 30, 872, 879 Wagner, P D, The multiple inert gas elimination technique (MIGET), Intensive Care Med, 2008, 34, 6, 994, 1001 Guerin, C, Reignier, J, Proseva Study Group, Prone positioning in Severe Acute Respiratory Distress Syndrome, N. Engl J Med, 2013, 368, 2159, 2168 Loscalzo, J, Oxidative Stress in Endothelial Cell Dysfunction and Thrombosis, Pathophys, Hemostasis, Thrombosis, 2002 Barbosa, Eduardo J. Mortani, Lanclus, Maarten, Vos, Wim, Van Holsbeke, Cedric, De Backer, William, De Backer, Jan, Lee, James, Machine Learning Algorithms Utilizing Quantitative CT Features May Predict Eventual Onset of Bronchiolitis Obliterans Syndrome After Lung Transplantation, Academic Radiology, 2018, 25, 9, 1201, 1212, 1076-6332, 10.1016/j.acra.2018.01.013, Elsevier BV, https://dx.doi.org/10.1016/j.acra.2018.01.013 Li, G, Fan, Y, Coronavirus Infections and Immune Responses, J. Medical Virology, 2020, 92, 424, 432 Wu, K, Peng, G, Mechanisms of Host Receptor Adaptation By Severe Acute Respiratory Syndrome Due To Coronavirus, J. Biol Chem, 2012, 287, 12, 8904, 8411 Leng, Z, Zhu, R, Transplantation of ACE2 Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia, J. Aging & Dis, 2020, 11, 2, 216, 228 Bi, X, Su, Z, Prediction of Severe Illness Due To COVID-19 Based On An Analysis of Initial Fibrinogen to Albumin Ratio and Platelet Count, Platelets, 2020, 1, 6 Li, Guangdi, De Clercq, Erik, Therapeutic options for the 2019 novel coronavirus (2019-nCoV), Nature Reviews Drug Discovery, 2020, 19, 3, 149, 150, 1474-1776, 1474-1784, 10.1038/d41573-020-00016-0, Springer Science and Business Media LLC, https://dx.doi.org/10.1038/d41573-020-00016-0 Gattinoni, Luciano, Chiumello, Davide, Caironi, Pietro, Busana, Mattia, Romitti, Federica, Brazzi, Luca, Camporota, Luigi, COVID-19 pneumonia: different respiratory treatments for different phenotypes?, Intensive Care Medicine, 2020, 0342-4642, 1432-1238, 10.1007/s00134-020-06033-2, Springer Science and Business Media LLC, https://dx.doi.org/10.1007/s00134-020-06033-2 Schepens, T, Van Holsbeke, C, Assessing Regional PEEP- Related Airway Opening and Dilatation in ARDS Patients Using Functional Respiratory Imaging (FRI), ERS, 2015, 9, 1, 19 Metcalfe, S, Mesenchymal Stem Cells and Management of COVID-19 Pneumonia, Med in Drug Discovery, 2020